Novel selective ligands for free fatty acid receptors GPR120 and GPR40

ISSN： 0028-1298

Source： Naunyn-Schmiedeberg's Archives of Pharmacology, Vol.380, Iss.3, 2009-09, pp. : 247-255

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

GPR40 Carboxylic Acid Receptor Family and Diabetes: A New Drug Target

Current Drug Targets, Vol. 9, Iss. 10, 2008-10 ,pp. : 899-910

Bentham Science Publishers

Access to resources Recommend Favorite

The therapeutic potential of GPR120: a patent review

By Halder Somnath Kumar Sanjay Sharma Rajiv

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 12, 2013-12 ,pp. : 1581-1590

Informa Healthcare

Access to resources Recommend Favorite

GPR 120: The Potential Target for Obesity Treatment

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 16, Iss. 1, 2016-03 ,pp. : 8-11

Bentham Science Publishers

Access to resources Recommend Favorite

Discovery of Selective Probes and Antagonists for G Protein-Coupled Receptors FPR/FPRL1 and GPR30

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 13, 2009-09 ,pp. : 1227-1236

Bentham Science Publishers

Access to resources Recommend Favorite

GPR40 Agonists for the Treatment of Type 2 Diabetes Mellitus: Benefits and Challenges

Current Drug Targets, Vol. 17, Iss. 11, 2016-07 ,pp. : 1292-1300

Bentham Science Publishers

Access to resources Recommend Favorite